Search for dissertations about: "cost-of-illness"
Showing result 1 - 5 of 20 swedish dissertations containing the word cost-of-illness.
-
1. Centralized Ovarian Cancer Care - Complications, Costs and Survival
Abstract : Background: Ovarian cancer is often diagnosed at advanced stages, and its mortality is high. Surgical treatment of advanced ovarian cancer strives toward complex primary debulking surgery (PDS), aiming for complete cytoreduction (R0) and improved survival. READ MORE
-
2. The treatment of back and neck pain. Cost and utility
Abstract : Aims To analyze the costs and effects of treatments used to return persons sick-listed due to back or neck problems to work, and to perform a cost-utility analysis of such treatments.Study population and Methods Included were men and women between the ages of 18 and 59 years who were employed but sick-listed (100 %) for at least 28 days due to a low back or neck diagnosis. READ MORE
-
3. The burden of stroke in Sweden : studies on costs and quality of life based on Riks-Stroke, the Swedish stroke register
Abstract : The costs for stroke management and reduced health related quality of life (QoL) can extend throughout life as mental and physical disabilities are common. The aim of this thesis was to quantify this stroke-related burden with data from Riks-Stroke (RS), the Swedish stroke register. READ MORE
-
4. Disease activity, function and costs in early rheumatoid arthritis
Abstract : Rheumatoid arthritis (RA) is a major cause of progressive joint damage and disability, and is associated with decline in quality of life, reduced ability to work and increased health care utilisation. The economic consequences of the disease are substantial for the individuals and their families and for the society as a whole. READ MORE
-
5. Health economics and its measures in rheumatoid arthritis
Abstract : Objectives: To study: (I) the impact on cost-utility analyses of applying different national EuroQol 5-Dimensions (EQ-5D) preference sets; (II and III) whether, in methotrexate-refractory, early rheumatoid arthritis (RA), the addition of infliximab results in superior health-related quality of life (HRQoL) and may be considered cost-effective, as compared to adding sulfasalazine and hydroxychloroquine; (IV) how costs relate to disability (measured by the health-assessment questionnaire, HAQ), disease activity (28-joint disease activity score, DAS28) and HRQoL (EQ-5D) in RA. Methods: In the observational SSATG register, one-year quality-adjusted life-year (QALY) accumulation of two interventions was compared according to the UK, US, or Danish EQ-5D preference sets. READ MORE